PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil
Copyright © 2019 Elsevier GmbH. All rights reserved..
Serological tests for subclinical Mycobacterium leprae infection based on antibodies to phenolic glycolipid-1 (PGL-1) and leprosy IDRI diagnostic-1 (LID-1) have not been compared in HIV-infected and uninfected individuals. PGL-1 seropositivity by ELISA was 6.0 % (21/350) in HIV-infected compared with 29.1 % (102/350) in HIV-uninfected individuals (p < 0.001); LID-1 seropositivity was 45.4 % (159/350) in HIV-infected compared with 50.3 % (153/304) in HIV-uninfected individuals (p = 0.21). In HIV-infected individuals, LID-1 but not PGL-1 antibody levels were inversely associated with CD4+ cell count (p = 0.02). These differential associations of HIV infection and CD4 count with PGL-1 and LID-1 have implications for M leprae immunodiagnostic tools and require replication.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:225 |
---|---|
Enthalten in: |
Immunobiology - 225(2020), 1 vom: 10. Jan., Seite 151866 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Madureira, Brunela Pitanga [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies, Bacterial |
---|
Anmerkungen: |
Date Completed 07.01.2021 Date Revised 07.01.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.imbio.2019.11.001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM303601582 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM303601582 | ||
003 | DE-627 | ||
005 | 20231225113153.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.imbio.2019.11.001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1011.xml |
035 | |a (DE-627)NLM303601582 | ||
035 | |a (NLM)31757558 | ||
035 | |a (PII)S0171-2985(19)30282-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Madureira, Brunela Pitanga |e verfasserin |4 aut | |
245 | 1 | 0 | |a PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.01.2021 | ||
500 | |a Date Revised 07.01.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 Elsevier GmbH. All rights reserved. | ||
520 | |a Serological tests for subclinical Mycobacterium leprae infection based on antibodies to phenolic glycolipid-1 (PGL-1) and leprosy IDRI diagnostic-1 (LID-1) have not been compared in HIV-infected and uninfected individuals. PGL-1 seropositivity by ELISA was 6.0 % (21/350) in HIV-infected compared with 29.1 % (102/350) in HIV-uninfected individuals (p < 0.001); LID-1 seropositivity was 45.4 % (159/350) in HIV-infected compared with 50.3 % (153/304) in HIV-uninfected individuals (p = 0.21). In HIV-infected individuals, LID-1 but not PGL-1 antibody levels were inversely associated with CD4+ cell count (p = 0.02). These differential associations of HIV infection and CD4 count with PGL-1 and LID-1 have implications for M leprae immunodiagnostic tools and require replication | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HIV | |
650 | 4 | |a LID-1 | |
650 | 4 | |a Leprosy | |
650 | 4 | |a PGL-1 | |
650 | 7 | |a Antibodies, Bacterial |2 NLM | |
650 | 7 | |a Antigens, Bacterial |2 NLM | |
650 | 7 | |a Glycolipids |2 NLM | |
650 | 7 | |a Lipid Droplet Associated Proteins |2 NLM | |
650 | 7 | |a phenolic glycolipid I, Mycobacterium leprae |2 NLM | |
700 | 1 | |a de Carvalho, Fernanda Marques |e verfasserin |4 aut | |
700 | 1 | |a Pessolani, Maria Cristina |e verfasserin |4 aut | |
700 | 1 | |a Collin, Simon Michael |e verfasserin |4 aut | |
700 | 1 | |a Deps, Patrícia Duarte |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Immunobiology |d 1985 |g 225(2020), 1 vom: 10. Jan., Seite 151866 |w (DE-627)NLM000456020 |x 1878-3279 |7 nnns |
773 | 1 | 8 | |g volume:225 |g year:2020 |g number:1 |g day:10 |g month:01 |g pages:151866 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.imbio.2019.11.001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 225 |j 2020 |e 1 |b 10 |c 01 |h 151866 |